A Cancer Driven by Ultra-Rare Mutation Gets Its First FDA-Approved Therapy

Frank Vinluan / medcitynews - Partner Therapeutics’ Bizengri is now FDA approved for treating advanced cases of cholangiocarcinoma driven by NRG1 gene fusions. Partner acquired U.S. rights to this bispecific antibody from Merus in 2024. The post A Cancer Driven by Ultra-Rare Mutation …

AI Summary: The FDA approved zenocutuzumab‑zbco for NRG1‑fusion–positive cholangiocarcinoma, delivering the first cleared therapy for cancers driven by this ultra‑rare genomic alteration. Trial data showed meaningful responses in heavily pretreated patients, prompting regulators to greenlight a precision option that offers targeted benefit where none existed — a small‑population win for genomic oncology.

With Commissioner Under Pressure, F.D.A. Opens Door to Flavored Vapes

Christina Jewett / nytimes - Though illicit e-cigarettes have flooded in from China, the new policy could allow major tobacco companies to sell from prime shelf space at thousands of stores.

AI Summary: Facing mounting pressure, the FDA has signaled authorization of fruit‑flavored vaping products for adults, a regulatory shift framed as adult access and harm reduction. Public‑health experts warn the move risks increasing youth appeal and reignites debate over flavors, enforcement, and whether potential population‑level tradeoffs were adequately considered.

500-year-old gold dental bridge is earliest known oral care of its kind in Scotland — and it likely held a fake tooth

livescience - Archaeologists discovered the 20-karat-gold dental wire in the lower jaw of a middle-aged man who lived around 500 years ago in Scotland.

AI Summary: Archaeologists uncovered what appears to be the earliest known gold dental bridge in Scotland, dating roughly four to five centuries ago and likely fitted with a faux tooth. The discovery sheds light on historic dental practice, craftsmanship and status signaling—proof that vanity and dental innovation are nothing new.